BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7242418)

  • 1. Minimal dose combined hormonal replacement therapy for menopausal women.
    Wren BG
    Med J Aust; 1981 Apr; 1(7):353-6. PubMed ID: 7242418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
    J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2003; 10(2):113-32. PubMed ID: 12627037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of micronized progesterone on the endometrium: a systematic review.
    Stute P; Neulen J; Wildt L
    Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hormones in the etiology and prevention of endometrial cancer.
    Gambrell RD
    Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal replacement regimens and bleeding.
    Dören M
    Maturitas; 2000 Jan; 34 Suppl 1():S17-23. PubMed ID: 10759060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive agents.
    Shearman RP
    Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of progesterone and progestins on endometrial proliferation.
    Moyer DL; Felix JC
    Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer risk under hormone therapy].
    Lauritzen C
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer and the use of estrogens.
    Gambrell RD
    Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
    Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen use in postmenopausal women.
    Kaunitz AM
    N Engl J Med; 1980 Dec; 303(25):1477-8. PubMed ID: 7432409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
    King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
    J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.